Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)

Phase 1

• Conditions: Parkinson's Disease
• Interventions: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

• Registration Number: NCT00674895
• Lead Sponsor: GAAD Medical Research Institute Inc.

Brief Summary

Parkinson's disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. This study will investigate the use of far infrared radiation to manage, control and treat PD.

Detailed Description

Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. PD is both chronic and progressive.

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.

It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have PD.

Study Timeline

• Study Start: 2008-05
• Study First Submitted: 2008-05-06
• Study First Submitted QC: 2008-05-07
• Study First Posted: 2008-05-08
• Status Verified: 2009-01
• Last Update Submitted: 2009-01-02
• Last Update Posted: 2009-01-05
• Primary Completion: 2010-05
• Study Completion: 2010-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• People with Parkinson's Disease

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Far Infrared Radiation (5μm to 20μm wavelength)	Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Primary Outcome Measures

Name	Time	Method
Cure for PD	2 years

Secondary Outcome Measures

Name	Time	Method
Rehabilitation of PD Patients	2 Years

Trial Locations

Locations (1)

The Centre for Incurable Diseases; 🇨🇦 Toronto, Ontario, Canada